However, cerebellum-associated developmental disorders and pediatric cerebellar tumors such as medulloblastoma are associated with deficits in procedural learning38–40, which could be exacerbated with prolonged Brd4 inhibitor usage. The gene discussed is BRD4; the disease is medulloblastoma.